Drug Shortage Report for BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP
Report ID | 47197 |
Drug Identification Number | 00037818 |
Brand name | BACTERIOSTATIC SODIUM CHLORIDE INJECTION USP |
Common or Proper name | Bacteriostatic Sodium Chloride |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 9MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 25x30mL PVL |
ATC code | B05CB |
ATC description | IRRIGATING SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-06-28 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-05-30 |
Shortage status | Avoided shortage |
Updated date | 2018-05-31 |
Company comments | 10mL and 20mL presentations remains available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2018-05-31 | French | Compare |
v3 | 2018-05-31 | English | Compare |
v2 | 2018-04-25 | French | Compare |
v1 | 2018-04-25 | English | Compare |
Showing 1 to 4 of 4